Figure 7
GP-specific iTreg down-regulated the T cell–stimulating capacity of DCs. GPIIb/IIIa-pulsed DCs were cultured alone (unmodulated DCs) or in the presence of GPIIb/IIIa-specific iTreg or conventional CD4+ GPIIb/IIIa-reactive T cells (Tconv) for 2 days. Then T cells were depleted using CD4 magnetic beads, and the isolated iTreg- or Tconv-modulated DCs (2 × 104) or unmodulated DCs (2 × 104) were used to stimulate CFSE-labeled GPIIb/IIIa-reactive T cells at a 1:10 ratio. After 3 days of culture, proliferation was measured as the percentage of proliferating GPIIb/IIIa-reactive T cells by flow cytometry. Results are representative of 16 independent experiments (A) and shown as mean plus or minus SD with error bars representing SD (B).

GP-specific iTreg down-regulated the T cell–stimulating capacity of DCs. GPIIb/IIIa-pulsed DCs were cultured alone (unmodulated DCs) or in the presence of GPIIb/IIIa-specific iTreg or conventional CD4+ GPIIb/IIIa-reactive T cells (Tconv) for 2 days. Then T cells were depleted using CD4 magnetic beads, and the isolated iTreg- or Tconv-modulated DCs (2 × 104) or unmodulated DCs (2 × 104) were used to stimulate CFSE-labeled GPIIb/IIIa-reactive T cells at a 1:10 ratio. After 3 days of culture, proliferation was measured as the percentage of proliferating GPIIb/IIIa-reactive T cells by flow cytometry. Results are representative of 16 independent experiments (A) and shown as mean plus or minus SD with error bars representing SD (B).

Close Modal

or Create an Account

Close Modal
Close Modal